Solubility of favipiravir (as an anti-COVID-19) in supercritical carbon dioxide: An experimental analysis and thermodynamic modeling.
Autor: | Sajadian SA; South Zagros Oil and Gas Production, National Iranian Oil Company, 7135717991 Shiraz, Iran.; Department of Chemical Engineering, Faculty of Engineering, University of Kashan, 87317-53153 Kashan, Iran., Ardestani NS; Department of Nanotechnology and Advanced Materials, Materials and Energy Research Center, 14155-4777 Karaj, Iran., Esfandiari N; Department of Chemical Engineering, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran., Askarizadeh M; Department of Chemical Engineering, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran., Jouyban A; Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.; Faculty of Pharmacy, Near East University, PO BOX: 99138, Mersin 10, Nicosia, North Cyprus,Turkey. |
---|---|
Jazyk: | angličtina |
Zdroj: | The Journal of supercritical fluids [J Supercrit Fluids] 2022 Apr; Vol. 183, pp. 105539. Date of Electronic Publication: 2022 Feb 04. |
DOI: | 10.1016/j.supflu.2022.105539 |
Abstrakt: | Favipiravir is one of the most commonly prescribed drugs in the treatment of COVID-19 in the early stages of the disease. In this work, the solubility of favipiravir was measured in supercritical CO Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2022 Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |